within Pharmacolibrary.Drugs.ATC.G;

model G03GA10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.64,
    Cl             = 0.005,
    adminDuration  = 600,
    adminMass      = 0.012,
    adminCount     = 1,
    Vd             = 0.008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Follitropin delta is a recombinant human follicle-stimulating hormone (r-hFSH) used for controlled ovarian stimulation in women undergoing assisted reproductive technologies such as in vitro fertilization. It is approved for clinical use as an infertility treatment.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy premenopausal women receiving follitropin delta by subcutaneous administration.</p><h4>References</h4><ol><li><a href='https://dx.doi.org/10.1111/cen.12623'>10.1111/cen.12623</a> PK parameters taken from Johansson G, et al. (2014, Clin Endocrinol (Oxf)). Parameter values were extracted for single dose administration in healthy premenopausal women. Dose is in Î¼g as per the marketed product. Bioavailability estimated relative to IV FSH (not marketed).</li></ol></body></html>",
    revisions = "<html><body><ul><li>03/06/2025 model generated from PK parameters and knowledge obtained by LLM gpt-4.1 and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03GA10;
